Queen’s University Belfast

Molecular Pathology is at the heart of delivering precision or personalised medicine. It is having a major impact clinically revolutionising how we diagnose and treat our patients. Molecular pathology integrates genomics, digital imaging and bioinformatics with modern pathology approaches to underpin molecular diagnostics, theranostics and clinical trials delivery within medical research, health services and industry.

This MSc programme at Queen’s University includes traditional and distance learning (DL) approaches to provide maximum flexibility. It focuses on innovation and entrepreneurship, addressing the ethos of Genomic Medicine in the 21st century. The course concentrates on the analysis of cancer using key technologies including high-throughput genomics (Next Generation Sequencing) and artificial intelligence (Digital Pathology).

This MSc will empower successful candidates to pursue a career in in academia, healthcare or industry.

The Molecular Pathology education programme at QUB has been developed with a number of options in order to provide maximum flexibility of training.

Further information on undertaking an Intercalated Degree at QUB is available on the School of Medicine, Dentistry & Biomedical Sciences webpages.

Entry requirements

An external medical or dental student wishing to intercalate must have successfully completed the third or fourth year of their course and passed all assessments in the year in which they are applying. External intercalating applicants should also ensure they have the permission of the Head of Undergraduate Medical/Dental Education or equivalent from their home University, which should be submitted to QUB Admissions Office.

Closing date

Friday 29 March 2019.  External candidates wishing to apply after this date should contact the School of Medicine, Dentistry & Biomedical Sciences directly by email at pgoffice.smdb@qub.ac.uk.